Standigm-preview

Standigm

Private

SeoulHealthcare & Life Scienceshttp://www.standigm.com

Last Round

Series C

Extension

Jul 6, 2021

Est. Valuation

$178M

Total Funding Raised

$80.55M

Company Overview

Standigm is a biotechnology company that provides an AI-based platform for drug discovery and development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Medical AI, Biotechnology, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Subscription SaaS

AI Layer

Application

Keywords

AI drug discoverydrug discovery platformtarget identificationlead compound designin silico drug discoveryAI biotechtechbiomolecular designcomputational drug discoverygenerative AI for drug discoverydrug repurposinggenerative chemistryADMET predictionpharma partnershipsdrug pipeline developmentout-licensingSaaS for drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Standigm Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Standigm Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series C Extension	Jul 6, 2021
Strategic	Jul 1, 2021
Series C	Mar 5, 2021
Strategic	Nov 20, 2019
Series B	Mar 29, 2019
Series A	Aug 1, 2016

View all Funding Rounds

Key People

Founding team and executive leadership

Sang Ok Song

Chief Executive Officer, Chief Technology Officer, Chief Scientific Officer, Co-founder And COO, Chief Transformation Officer Co-founder

Founding Team

YounSung Choo

Chief Executive Officer

Executive Team

InSuk Joung

Chief Technology Officer

Executive Team

Standigm Investors

Notable investors and investment history

Investor	Rounds
InterVest	Series C
DSC Investment	Series C, Series B
Kakao Ventures	Series A, Series C, Series B, Seed
Wonik Investment Partners	Series C, Series B
Pavilion Capital	Series C Extension
SKS Private Equity	Series C
Korea Development Bank	Series C

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 15, 2026
Monthly visitors grew 381% MoM, reaching 3.6K.

View all signals

Standigm Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Standigm Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Standigm's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul

Employee Range25

Year Founded2015

Last FundingJul 6, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.